TW Research Group | Micro-Cap Stock Ideas

Awaiting Liftoff…Catalyst List

Daniel Carlson - January 27, 2023

Jumping the gun by a couple days here, but January has been a very good month for stocks. The average stock in TW's universe...

Trading Update, January 27th 2023

Daniel Carlson - January 27, 2023

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

Movano Health Prices $6.5 Million Public Offering

Daniel Carlson - January 27, 2023

TW's Take: positive to get some financing done which should allow the company to achieve key milestones without additional financing. The biggest risk to...

INmune in DMD…Yet Another Indication of Future Success

Daniel Carlson - January 25, 2023

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne...

Daniel Carlson - January 25, 2023

TW's Take: exciting news as the "wonder drug" that is XPro demonstrates exciting data in yet another major, untreated disease. Boca Raton, Florida, Jan. 25,...

Looking for 3-5X This Year? These Two Jackpot Stocks Offer That Potential

Daniel Carlson - January 21, 2023

In 2022, interest rates killed micro-cap. This year, with increased expectations of a recession and an associated end of rate increases, the smaller stocks...

Spectra7 Announces Preliminary Fourth Quarter and Annual Financial Results for the Year Ended December...

Daniel Carlson - January 18, 2023

TW's Take: Glad to see that the company will be approaching, if not achieving, EBITDA positive operations very soon. Stabilizing the cash flows and...

enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer

Daniel Carlson - January 18, 2023

TW's Take: our view on NVNO remains that the product will gain approval and substantial sales, but likely remains off investors' radar screens until...

Notes for Premium Subscribers

Daniel Carlson - January 17, 2023

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

Lantern Pharma Receives Pre-IND Feedback from the FDA, Clearing a Path for Drug Candidate...

Daniel Carlson - January 17, 2023

TW's Take: continued execution as they move this incredibly promising drug into human trials sometime in the not too distant future. LTRN still trading...

The January Halftime Report

Daniel Carlson - January 14, 2023

It has been a great start to 2023, particularly for smaller, growth stocks. The most likely explanation for this is investor expectations regarding inflation...

The 2023 Game Plan

Daniel Carlson - January 10, 2023

Entering 2023, I'm fairly confident that everyone who subscribes to TW's service knows my thoughts on the overall market. In a nutshell, I believe...

Spectra7, ACON, and Mo-Link to Demonstrate Thunderbolt 4 Active Copper Cables at CES 2023

Daniel Carlson - January 10, 2023

TW's Take: when SPVNF finally starts ramping sales of active copper cables into data centers, the stock should launch. LAS VEGAS, Jan. 5, 2023 /PRNewswire/ -- (TSXV:...

TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer

Daniel Carlson - January 9, 2023

TW's Take: this is a great step, bringing in house the expertise needed to take products through clinical development and commercialization or partnering. FORT WORTH,...

For The TW Portfolio, Our FATE Awaits

Daniel Carlson - January 7, 2023

This past week, thanks to a big move on Friday, saw the markets start the new year on a positive note. Investors increasingly believe...

IN8bio Provides INB-200 Clinical Update and Outlines 2023 Pipeline Goals

Daniel Carlson - January 5, 2023

TW's Take: Gamma-Delta T-Cells is a very hot space and IN8bio is proving to be a leader here. The stock is dramatically undervalued relative...

IN8bio to Present at Biotech Showcase 2023 in San Francisco

Daniel Carlson - January 3, 2023

TW's Take: expecting good news from their GBM program this coming week before they start presenting to investors in San Francisco. NEW YORK, Jan. 03,...

The Light at the End of the Tunnel

Daniel Carlson - December 31, 2022

In the hills just west of Charlottesville lies the Crozet Tunnel. Built in the mid 1800's, it was a major supply route in the...

Trading Thoughts As We Prepare To Swap Out The Calendar

Daniel Carlson - December 29, 2022

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

Movano Health Unveils Evie: First Medical Grade Smart Ring Designed Uniquely for Women

Daniel Carlson - December 28, 2022

TW's Take: if they can get FDA approved, will be a key differentiation versus the competition. Movano is significantly undervalued relative to peers and...

Receive Our Weekly Newsletter

Every Sunday we recap the market and consolidate the news from our universe. It’s free to subscribe. Just click on the link below.

Newsletter Signup

Premium Membership

For those interested in doing a deeper dive into our coverage universe, we offer premium membership. Benefits of being a premium member include the following:

First Look: new names added to the portfolio, or stocks being removed, are shared with premium subscribers before anyone else.

Trade Alerts: when actionable events occur, we highlight the opportunities in an email to our premium subscribers

TW Private Chat Room: premium members have access to our exclusive chat room where more research and ideas are freely shared amongst the whole community.

SIGN ME UP

Home